HEPATOTOXIQUES DU CHLORDECONE

[LES EFFETS HEPATOTOXIQUES DU CHLORDECONE]19cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis ».Hepatology (Baltimore, Md.) (juillet 14, 2012). doi:10.1002/hep.25951.‣ Mehendale, H M, et S D Ray. « Inhibition of cell division in hepatoma cell cultures bychlordecone and carbon tetrachloride combination ». Toxicology in vitro: an internationaljournal published in association with BIBRA 4, n o 3 (1990): 179-183.‣ Multigner, Luc, Jean Rodrigue Ndong, Arnaud Giusti, Marc Romana, Helene Delacroix-Maillard, Sylvaine Cordier, Bernard Jégou, Jean Pierre Thome, et Pascal Blanchet.« Chlordecone exposure and risk of prostate cancer ». Journal of clinical oncology: officialjournal of the American Society of Clinical Oncology 28, n o 21 (juillet 20, 2010): 3457-3462.doi:10.1200/JCO.2009.27.2153.‣ Murali, B, M C Korrapati, Alan Warbritton, John R Latendresse, et Harihara M Mehendale.« Tolerance of aged Fischer 344 rats against chlordecone-amplified carbon tetrachloridetoxicity ». Mechanisms of ageing and development 125, n o 6 (juin 2004): 421-435.doi:10.1016/j.mad.2004.03.005.‣ Repa, Joyce J, Knut E Berge, Chris Pomajzl, James A Richardson, Helen Hobbs, et David JMangelsdorf. « Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8by the liver X receptors alpha and beta ». The Journal of biological chemistry 277, n o 21 (mai24, 2002): 18793-18800. doi:10.1074/jbc.M109927200.‣ Scheri, Richard C, Junga Lee, Douglas F Barofsky, et Lawrence R Curtis. « Chlordeconeincreased subcellular distribution of scavenger receptor class B type II to murine hepaticmicrosomes without altering cytosolic cholesterol binding proteins ». Toxicology letters 191,n o 1 (décembre 1, 2009): 20-25. doi:10.1016/j.toxlet.2009.07.029.‣ Seurin, Sophie, Florence Rouget, Jean-Cédric Reninger, Nadège Gillot, Claire Loynet,Sylvaine Cordier, Luc Multigner, Jean-Charles Leblanc, Jean-Luc Volatier, et Fanny Héraud.« Dietary exposure of 18-month-old Guadeloupian toddlers to chlordecone ». Regulatorytoxicology and pharmacology: RTP 63, n o 3 (août 2012): 471-479.doi:10.1016/j.yrtph.2012.05.009.‣ Tarao, Kazuo, Kaoru Miyakawa, Yohei Miyagi, Shinichi Ohkawa, Soichiro Morinaga, KenjiOshige, Naoto Yamamoto, et al. « Severe inflammation in the background liver cirrhosiscorrelates with the development of poorly differentiated HCC in HCV-associated livercirrhosis ». Internal medicine (Tokyo, Japan) 51, n o 18 (2012): 2495-2501.SIMON LETACONNOUX Synthèse Bibliographique MASTER BIOLOGIE-GESTION 2012/2013